Actively Recruiting
A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy
Led by M.D. Anderson Cancer Center · Updated on 2025-11-13
224
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
CONDITIONS
Official Title
A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older
- Patients undergoing initial partial or complete thyroid lobectomy
- English and non-English speaking patients are eligible
You will not qualify if you...
- Increased bleeding risk (e.g., aspirin, antiplatelet therapy, or anticoagulation not stopped 5 days before surgery, or baseline platelet count below 50,000/µL)
- Medical conditions or poor performance status (ECOG > 2) requiring overnight hospital observation
- Living more than 50 miles from the hospital or inability to stay within 50 miles after surgery
- Living alone or unable to perform daily activities without a caregiver available for postoperative days 0 to 3
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
P
Paul Graham, M D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here